Too Old to Operate21h
LUNA 3: Rilzabrutinib Meets Primary Endpoint in ITP
Rilzabrutinib improved efficacy and QOL outcomes among pre-treated adult patients with immune thrombocytopenia.
Too Old to Operate21h
Menin Inhibitors on the Rise in KMT2Ar Acute Leukemia
Revumenib displayed promising anti-tumor activity among patients with relapsed or refractory KMT2Ar acute leukemia.
Too Old to Operate22h
PIVOT: Can Hydroxyurea Improve Outcomes in HbSC?
Hydroxyurea showed more dose-limiting toxicities than placebo but reduced clinical AEs and improved hematological parameters, ...
Too Old to Operate22h
The Holidays: A Double-Edged Sword Against Cardiac Health
The holiday season increases cardiac risks and reduces medical access, making proactive cardiac health strategies essential ...